Neil Kumar is the founder of BridgeBio. BridgeBio has raised $349M in total funding. Latest round: IPO. Based in Palo Alto, California.
Neil Kumar is the founder and CEO of BridgeBio, a pioneering biotech company that develops genetically targeted medicines to treat patients with genetic diseases. He has built a new biotech model focused on accelerating drug development for underrepresented genetic conditions.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide